Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. [electronic resource]
- International journal of medical sciences 2015
- 63-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't